In patients with stage Ta T1 urothelial bladder cancer, intravesical chemotherapy and bacillus Calmette-Guérin (BCG) both reduce the recurrence rate, but the benefit of BCG relative to chemotherapy for long term endpoints is controversial, especially i
A meta-analysis performed by the MetaGIST consortium compared two doses of imatinib, 400 mg once daily versus 400 mg twice daily, in 1640 patients with advanced gastrointestinal stromal tumors (GIST).
Following months of planning, the EORTC Imaging Group has been reborn and will hold its first meeting on 15 January 2010 at the Universiteit Antwerpen, Belgium.
Historically, some of the strengths of the EORTC have been its ability to conduct cancer clinical trials designed to optimize therapeutic strategies, to address specific niches such as rare tumors, and to apply a multidisciplinary treatment approach.
The EORTC Radiation Oncology Group (ROG) Quality Assurance in Radiotherapy (QA RT) Strategy Committee and Team would like to provide you with this update on some of its recent achievements and activities.
The EORTC Quality of Life (QOL) course, Quality of Life, Symptom Research, and Patient Reported Outcomes in Cancer Clinical Trials, 25-27 November 2009, Brussels, was attended by over 230 partici
At the 2009 MASCC (Multinational Association for Supportive Care in Cancer) / ISOO (International Society of Oral Oncology) International Symposium held in Rome this past June, Chantal Quinten, a statistical researcher in the Quality of Life Department
The largest ever performed meta-analysis of health related quality of life (HRQOL) data of the EORTC QLQ-C30 was performed by Chantal Quinten and coworkers, from the EORTC Quality of Life Department, on behalf of the EORTC Clinical Groups.[1] This larg
